The first high-tech artificial heart was implanted in patients with severe heart disease a decade ago. But since then, a revolution in heart replacements has failed to materialize. Why is that?
Carmat said it expected growth in European sales, with revenue of between €4 million-€6 million in the second half of 2023, and for a subsequent sharp increase in sales in 2024.
Artificial heart maker Carmat
, whose financial situation has been under pressure,
said on Monday that it had completed a 7 million euro capital raising backed by several of its.
French heart firm Carmat gets lifeline without new Airbus cash kitco.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kitco.com Daily Mail and Mail on Sunday newspapers.
Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture.